Cas:864684-82-2 methyl 2-fluoro-3,4,5-trimethoxybenzoate manufacturer & supplier

We serve Chemical Name:methyl 2-fluoro-3,4,5-trimethoxybenzoate CAS:864684-82-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

methyl 2-fluoro-3,4,5-trimethoxybenzoate

Chemical Name:methyl 2-fluoro-3,4,5-trimethoxybenzoate
CAS.NO:864684-82-2
Synonyms:Benzoic acid,2-fluoro-3,4,5-trimethoxy-,methyl ester;2-FLUORO-3,4,5-TRIMETHOXY-BENZOIC ACID METHYL ESTER
Molecular Formula:C11H13FO5
Molecular Weight:244.21600
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:53.99000
Exact Mass:244.07500
LogP:1.63810

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Benzoic acid,2-fluoro-3,4,5-trimethoxy-,methyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-FLUORO-3,4,5-TRIMETHOXY-BENZOIC ACID METHYL ESTER physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-FLUORO-3,4,5-TRIMETHOXY-BENZOIC ACID METHYL ESTER Use and application,2-FLUORO-3,4,5-TRIMETHOXY-BENZOIC ACID METHYL ESTER technical grade,usp/ep/jp grade.


Related News: Conducted by Innovent in China, the CIBI321A101 trial is a Phase 1a open-label, multi-center study of the safety, tolerability and primary efficacy of IBI321 in patients with advanced solid tumors. Phase 1a of the study will evaluate dosing of IBI321 in a variety of solid tumors (ClinicalTrials.gov, NCT04911894). 4-amino-1-(O4-β-D-glucopyranosyl-β-D-glucopyranosyl)-1H-pyrimidine-2-thione manufacturers Capturing multiple aspects of improvement increases confidence that anifrolumab may be an important option for patients.” bromo-3 dihydro-5,6 methyl-6 pyridone-2 suppliers “His strong track record of success and deep experience of fast-moving consumer goods and consumer health, proven at P&G, Novartis and GSK, means he is the right choice” to lead the consumer health unit as an independent company, GSK Chairman Jonanthan Symonds said of McNamara in the statement. (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2-ethyl-3,4,10,13-tetrahydroxy-3,5,8,10,12,14-hexamethyl-6-(3-((thiazol-2-ylmethyl)amino)propyl)-1-oxa-6-azacyclopentadecan-15-o vendor & factory.